Effect of charred Radix et Rhizoma Rhei in a laser-induced choroidal neovascularization murine model

被引:8
|
作者
Han, Dongmei [1 ]
Yao, Yuan [1 ]
Sun, Yong [1 ]
Gong, Yuanyuan [1 ]
Wu, Xingwei [1 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Dept Ophthalmol, Shanghai 200080, Peoples R China
关键词
charred Radix et Rhizoma Rhei; choroidal neovascularization; traditional Chinese medicine; age-associated macular degeneration; interleukin-10; MACULAR DEGENERATION; ANGELICA-SINENSIS; INTRAVITREAL TRIAMCINOLONE; ANTIINFLAMMATORY ACTIVITY; PHOTODYNAMIC THERAPY; PANAX-NOTOGINSENG; PORIA-COCOS; IN-VITRO; EXTRACT; EXPRESSION;
D O I
10.3892/mmr.2014.3046
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A pharmaceutical composition (patent no. WO2012079419) exhibited favorable outcomes in a clinical trial of wet age-related macular degeneration. The aims of the present study were to explore the effects of one composition component, charred Radix et Rhizoma Rhei (CRRR), in a laser-induced choroidal neovascularization (CNV) murine model. A total of 30 eight-week-old C57BL/6 mice were subjected to diode laser treatment, and CNV was induced by rupturing the Bruch's membrane. The mice were then randomly divided into two groups: the CRRR-treated group that was administered CRRR water extract (concentration, 0.6 g/100 ml; dose, 1 ml/0.1 kg twice a day for 21 days); and the control group that was treated with saline (dose, 1 ml/0.1 kg twice a day for 21 days). The retinal tissue was subjected to quantitative polymerase chain reaction (qPCR) and western blot analysis to determine the expression levels of interleukin-10 (IL-10) and vascular epithelial growth factor (VEGF) at day seven following laser treatment. At weeks 2 and 3 after laser treatment, fundus fluorescein angiography was performed and graded to assess the severity of lesion leakage. Retinal flat mounts were prepared for three-dimensional confocal microscopy at day 22 after laser treatment. At days 14 and 21 after laser treatment, no statistically significant differences were observed between the clinically relevant lesions of the CRRR-treated and control mice. CNV volumes were not found to be significantly different between the CRRR-treated and control mice. The expression levels of IL-10 were significantly increased in the CRRR-treated mice (P<0.05). However, no statistically significant differences were observed between the VEGF expression levels of the CRRR-treated and control mice. In conclusion, CRRR did not appear to significantly inhibit CNV in this murine model. The function of CRRR in the pharmaceutical composition may be due to the effects of IL-10 and a synergistic effect with other components of the composition. However, further investigation is required.
引用
收藏
页码:2896 / 2902
页数:7
相关论文
共 50 条
  • [41] Alexandrite Laser-Induced Choroidal Neovascularization Successfully Treated With Aflibercept
    Diafas, Asterios
    Stampouli, Despoina
    Dastiridou, Anna
    Androudi, Sofia
    Brazitikos, Periklis
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (05)
  • [42] Silencing fibroblast growth factor 7 inhibits krypton laser-induced choroidal neovascularization in a rat model
    Zhang, Chao
    Han, Mei
    Wu, Shuai
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 120 (08) : 13792 - 13801
  • [43] Genetic deficiency and pharmacological modulation of RORα regulate laser-induced choroidal neovascularization
    Liu, Chi-Hsiu
    Yemanyi, Felix
    Bora, Kiran
    Kushwah, Neetu
    Blomfield, Alexandra K.
    Kamenecka, Theodore M.
    SanGiovanni, John Paul
    Sun, Ye
    Solt, Laura A.
    Chen, Jing
    AGING-US, 2023, 15 (01): : 37 - 52
  • [44] Inhibition of new vessel growth in mouse model of laser-induced choroidal neovascularization by adiponectin peptide II
    Lyzogubov, Valeriy V.
    Tytarenko, Ruslana G.
    Thotakura, Sushma
    Viswanathan, Tito
    Bora, Nalini S.
    Bora, Puran S.
    CELL BIOLOGY INTERNATIONAL, 2009, 33 (07) : 765 - 771
  • [45] Genetic loci that control the size of laser-induced choroidal neovascularization
    Nakai, Kei
    Rogers, Michael S.
    Baba, Takashi
    Funakoshi, Taisaku
    Birsner, Amy E.
    Luyindula, Dema S.
    D'Amato, Robert J.
    FASEB JOURNAL, 2009, 23 (07) : 2235 - 2243
  • [46] Optimization of laser-induced choroidal neovascularization in African green monkeys
    Goody, Robin J.
    Hu, Wenzheng
    Shafiee, Afshin
    Struharik, Michael
    Bartels, Stephen
    Lopez, Francisco J.
    Lawrence, Matthew S.
    EXPERIMENTAL EYE RESEARCH, 2011, 92 (06) : 464 - 472
  • [47] Inhibition of TNF-α reduces laser-induced choroidal neovascularization
    Shi, Xuan
    Semkova, Irina
    Muether, Philipp S.
    Dell, Susanne
    Kociok, Norbert
    Joussen, Antonia M.
    EXPERIMENTAL EYE RESEARCH, 2006, 83 (06) : 1325 - 1334
  • [48] Reliability of the Mouse Model of Choroidal Neovascularization Induced by Laser Photocoagulation
    Poor, Stephen H.
    Qiu, Yubin
    Fassbender, Elizabeth S.
    Shen, Siyuan
    Woolfenden, Amber
    Delpero, Andrea
    Kim, Yong
    Buchanan, Natasha
    Gebuhr, Thomas C.
    Hanks, Shawn M.
    Meredith, Erik L.
    Jaffee, Bruce D.
    Dryja, Thaddeus P.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (10) : 6525 - 6534
  • [49] Intravitreal CendR peptides target laser-induced choroidal neovascularization sites in mice
    Puranen, Jooseppi
    Korhonen, Sonja
    Haugas, Maarja
    Lingasamy, Prakash
    Teesalu, Tambet
    Subrizi, Astrid
    Urtti, Arto
    Ruponen, Marika
    Reinisalo, Mika
    JOURNAL OF CONTROLLED RELEASE, 2023, 360 : 810 - 817
  • [50] Endogenous Osteopontin Involvement in Laser-Induced Choroidal Neovascularization in Mice
    Fujita, Norihito
    Fujita, Shuko
    Ogata, Nahoko
    Matsuoka, Masato
    Okada, Yuka
    Kon, Shigeyuki
    Uede, Toshimitsu
    Saika, Shizuya
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2011, 52 (13) : 9310 - 9315